ExpreS2ion Biotech
ExpreS2ion publishes video presentations from Biostock Life Science Summit and Analysguiden Stora Aktiedagarna
The first presentation was delivered at the Biostock Life Science Summit on 21 November 2024. The second took place at the Aktiespararna event Stora Aktiedagarna in Stockholm on 27 November 2024. Both presentations highlighted ExpreS2ion's novel HER2-targeted therapeutic cancer vaccine program, ES2B-C001, and the company's progress toward key milestones.
Key topics covered include:
- The unmet medical need for HER2-positive cancer treatments and the transformative potential of ES2B-C001
- Strong preclinical data, demonstrating significant tumour growth inhibition and survival outcomes
- The company's integrated development plan (iDP), positioning ExpreS2ion for value creation through strategic milestones, including the anticipated decision on the Phase I clinical trial application.
The presentations can be found on the Company's investor website via the following link: https://investor.expres2ionbio.com/presentations/
Certified Adviser
Svensk Kapitalmarknadsgranskning AB
| Datum | 2024-12-02, kl 12:45 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!